The Value Science Company ™

Syenza™ is a life science consultancy for accelerating value based healthcare systems. Our specialised services include Pricing Consulting, Market Access Consulting, and Healthcare Consulting.

Get in touch

Some of the organizations we have worked with.

What do our services include?

Pricing Consulting

Value-based Health Care depends on a rigorous approach to evaluating the price of innovations. Full pricing is out, shared-value is in.

Read more

Market Access Consulting

Market Access requires a new approach to Value-based Health Care. Old tools are out, value-based methods are in.

Read more

Healthcare Consulting

Value-based Health Care changes how we look at healthcare systems. It's no longer business as usual.

Read more

Our Story

Syenza ™ builds on our heritage at C&C - The Specialist Market Access Firm ™. Along the way we’ve learnt that accelerating value-based healthcare systems will require specialised expertise in pricing, market access, and healthcare consulting. We’ve come a long way.

Contact Us
January 2008

Our Founder starts consulting at WHO and Harvard Medical School

March 2011

We start accepting outsourced projects from prominent consulting firms

June 2015

We strengthen our market access and pharmacoeconomics services for pain management and rare diseases.

September 2016

We introduce our Client Chart and start working direct with top Clients

June 2017

Our therapeutic area pharmacoeconomic projects cover cancer, CVD, rheumatoid arthritis, epilepsy, multiple sclerosis, HIV/AIDS.

April 2018

We introduce the first fully online applied pharmacoeconomics course.

September 2019

We’ve traveled a lot of miles implementing access projects, and delivered much analytics.

Since 2008, we have ...
Travelled
4,928,768 km

implementing Access Projects

Written
1,252 p.

presenting our Analytic Work

Delivered
320 h

of Market Access Workshops

Exchanged Views in
21,384 min

of Global Conferencing

Our Team

Teresa

Project Executive

João

Chief Executive

René

Research Director

Althea

Research Consultant

Contact Us

Most popular articles

Value-Based Pricing of New Healthcare Technologies

What is value-based pricing of new healthcare technologies? Value-based pricing aims to reward pharmaceutical companies and medical device companies for investments in new healthcare technologies that result in sustained improvements in patient quality of life. We also expect such technologies to deliver measurable net economic benefits for society. In economic theory, value-based pricing is when […]

Read all
Budget Impact Analysis of Healthcare Technologies

What is Budget Impact Analysis? Pharmacoeconomic analyses in healthcare are paramount, because of the high costs of innovative technologies and limited possibilities of their funding. Budget Impact Analysis (BIA) is one such analysis that provides vital information for healthcare decision makers. [1] Unlike economic evaluations, such as cost-effectiveness analysis (CEA), cost-utility analysis (CUA) and cost-benefit […]

Read all
The Pharma Market Access Landscape in the Middle East and North Africa: The Next Ten Years

Introduction The market access landscape in the Middle East and North Africa (MENA) is dynamic and rapidly changing. MENA is diverse, comprising many dissimilar countries, with different cultures, including languages, used in commerce. The concerns about the long-term sustainability of oil revenues are driving to shape healthcare markets. There are different approaches to regulating healthcare […]

Read all
Read all articles

What clients say about us?

Country Manager
Genzyme
Insight into proposed projects, and management of timelines and deliverables. Having articles on outcomes of the project once the project is completed.
Regional Market Access Manager
Boehringer Ingelheim
Self initiative to take the best path and overcome issues without seeking directions from us every time — saves everyone a lot of time and helps with timelines.
Senior Market Access Manager
Amgen
The collaborative efforts in defining the project, the discussions on the insights generated and follow-up and the further assistance that was offered in understanding the landscape.
Market Access Manager
Sanofi
The regular feedback and the commitment to timelines and delivery.
Global Public Affairs Director
Novo Nordisk
Dedicated and knowledgeable with a high interest in delivering value-adding outcomes.
Head of Market Access
Merck
Good insight into the market and new perspectives of looking at access.
Global Market Access Executive
Novo Nordisk
Expertise in the field, communication and constant project status reporting.

Client Charter

We are devoted to accelerating value-based healthcare systems. To this end, we commit to upholding essential principles in all of our dealings with clients. Our Client Charter is our promise to you that:

  • We will execute and complete all projects on time consistent with internationally accepted standards.
  • We will uphold inflexible data security and confidentiality standards.
  • We pledge to work with you to ensure our prices remain competitive.
  • We will never outsource your project or broker a contract to third parties.
  • We commit to including you in our project teams to transfer knowledge and skills.
  • We will respond to 100% of your correspondence within 24 hours.
  • We will be transparent and frank in our communication, no sugar-coating.

Ready to get started?

Contact Us